PAGLIARI, MARIA TERESA
PAGLIARI, MARIA TERESA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
ADAMTS13 activity, high VWF and FVIII levels in the pathogenesis of deep vein thrombosis
2021 M.T. Pagliari, M. Boscarino, A. Cairo, I. Mancini, I. Martinelli, P. Bucciarelli, F. Rossi, F.R. Rosendaal, F. Peyvandi
Differential diagnosis between type 2A and 2B von Willebrand disease in a child with a previously undescribed de novo mutation
2018 M.T. Pagliari, L. Baronciani, F. Stufano, P. Colpani, S.M. Siboni, F. Payvandi
Evaluation of a fully automated von Willebrand factor assay panel for the diagnosis of von Willebrand disease
2020 F. Stufano, L. Baronciani, P. Bucciarelli, M. Boscarino, P. Colpani, M.T. Pagliari, F. Peyvandi
Factor V Leiden but not factor II 20210G>A is a risk factor in a large cohort of Iranian patients with premature coronary artery disease
2020 I. Mancini, S. Sadeghian, M.T. Pagliari, S.H. Abbasi, H. Poorhosseini, M.A. Boroumand, M. Lotfi-tokaldany, E. Pappalardo, G. Colombo, F. Tafuri, P. Agosti, F.R. Rosendaal, F. Peyvandi
Factor V Leiden but Not Factor II 20210G>A Is a Risk Factor in a Large Cohort of Iranian Patients with Premature Coronary Artery Disease
2020 I. Mancini, S. Sadeghian, M.T. Pagliari, S.H. Abbasi, H. Poorhosseini, M.A. Boroumand, M. Lotfi-Tokaldany, E. Pappalardo, G. Colombo, F. Tafuri, P. Agosti, F.R. Rosendaal, F. Peyvandi
Next-generation sequencing and in vitro expression study of ADAMTS13 single nucleotide variants in deep vein thrombosis
2016 M.T. Pagliari, L.A. Lotta, H.G. De Haan, C. Valsecchi, G. Casoli, S. Pontiggia, I. Martinelli, S.M. Passamonti, F.R. Rosendaal, F. Peyvandi
PATHOPHYSIOLOGY OF VON WILLEBRAND FACTOR IN BLEEDING AND THROMBOSIS
2023 M.T. Pagliari
Risk of diagnostic delay in congenital thrombotic thrombocytopenic purpura
2019 B. Ferrari, A. Cairo, M. Pagliari, I. Mancini, S. Arcudi, F. Payvandi
Role of ADAMTS13, VWF and F8 genes in deep vein thrombosis
2021 M.T. Pagliari, A. Cairo, M. Boscarino, I. Mancini, E. Pappalardo, P. Bucciarelli, I. Martinelli, F.R. Rosendaal, F. Peyvandi
The ADAMTS13-von Willebrand factor axis in COVID-19 patients
2020 I. Mancini, L. Baronciani, A. Artoni, P. Colpani, M. Biganzoli, G. Cozzi, C. Novembrino, M. Boscolo Anzoletti, V. De Zan, M.T. Pagliari, R. Gualtierotti, S. Aliberti, M. Panigada, G. Grasselli, F. Blasi, F. Peyvandi
The dominant p.Thr274Pro mutation in the von Willebrand factor propeptide causes the von Willebrand disease type 1 phenotype in two unrelated patients
2022 M.T. Pagliari, L. Baronciani, C. Cordiglieri, P. Colpani, G. Cozzi, S.M. Siboni, F. Peyvandi
von Willebrand disease type 1 mutation p.Arg1379Cys and the variant p.Ala1377Val synergistically determine a 2M phenotype in four Italian patients
2016 M.T. Pagliari, L. Baronciani, F. Stufano, I. Garcia-Oya, G. Cozzi, F. Franchi, F. Peyvandi